Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Cornberg

Showing results (231-240 of 350) with videos related to

Pageof 35
Sort By:
Hepatology (Baltimore, Md.)|December 19, 2024
Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibitionMelanie Urbanek-Quaing, Yin-Han Chou, Manoj Kumar Gupta, et al.
Journal of Hepatology|February 17, 2020
Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: A meta-analysisPietro Lampertico, Jose A Carrión, Michael Curry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 25, 2015
Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa-2a in hepatitis C null respondersBalazs Fülöp, Michael Biermer, Markus Cornberg, et al.
Hepatology Communications|July 7, 2020
HBV-RNA Co-amplification May Influence HBV DNA Viral Load DeterminationBenjamin Maasoumy, Anna Maria Geretti, André Frontzek, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 1, 2018
Systemic inflammation and immune cell phenotypes are associated with neuro-psychiatric symptoms in patients with chronic inflammatory liver diseasesAmare Aregay, Meike Dirks, Verena Schlaphoff, et al.
Frontiers in Immunology|August 30, 2021
Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell TherapyBerislav Bošnjak, Ivan Odak, Christiane Ritter, et al.
Hepatology (Baltimore, Md.)|June 19, 2023
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patientsAndré Gömer, Mara Klöhn, Michelle Jagst, et al.
European Journal of Immunology|November 29, 2021
Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatmentYanqin Du, Tanvi Khera, Benedikt Strunz, et al.
The Lancet. Gastroenterology & Hepatology|July 27, 2025
Scientific and medical evidence informing expansion of hepatitis B treatment guidelinesPatrick T Kennedy, Lena Allweiss, Antonio Bertoletti, et al.
Scientific Reports|October 3, 2019
Soluble immune markers in the different phases of chronic hepatitis B virus infectionSteffen B Wiegand, Bastian Beggel, Anika Wranke, et al.
Pageof 35

Showing results (231-240 of 350) with videos related to

Sort By:
Pageof 35
Hepatology (Baltimore, Md.)|December 19, 2024
Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibitionMelanie Urbanek-Quaing, Yin-Han Chou, Manoj Kumar Gupta, et al.
Journal of Hepatology|February 17, 2020
Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: A meta-analysisPietro Lampertico, Jose A Carrión, Michael Curry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 25, 2015
Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa-2a in hepatitis C null respondersBalazs Fülöp, Michael Biermer, Markus Cornberg, et al.
Hepatology Communications|July 7, 2020
HBV-RNA Co-amplification May Influence HBV DNA Viral Load DeterminationBenjamin Maasoumy, Anna Maria Geretti, André Frontzek, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 1, 2018
Systemic inflammation and immune cell phenotypes are associated with neuro-psychiatric symptoms in patients with chronic inflammatory liver diseasesAmare Aregay, Meike Dirks, Verena Schlaphoff, et al.
Frontiers in Immunology|August 30, 2021
Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell TherapyBerislav Bošnjak, Ivan Odak, Christiane Ritter, et al.
Hepatology (Baltimore, Md.)|June 19, 2023
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patientsAndré Gömer, Mara Klöhn, Michelle Jagst, et al.
European Journal of Immunology|November 29, 2021
Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatmentYanqin Du, Tanvi Khera, Benedikt Strunz, et al.
The Lancet. Gastroenterology & Hepatology|July 27, 2025
Scientific and medical evidence informing expansion of hepatitis B treatment guidelinesPatrick T Kennedy, Lena Allweiss, Antonio Bertoletti, et al.
Scientific Reports|October 3, 2019
Soluble immune markers in the different phases of chronic hepatitis B virus infectionSteffen B Wiegand, Bastian Beggel, Anika Wranke, et al.
Pageof 35